Understanding healthcare providers’ preferred attributes of pediatric pneumococcal conjugate vaccines in the United States
Autor: | Salini Mohanty, Jui-Hua Tsai, Ning Ning, Ana Martinez, Rishi P. Verma, Marieke Heisen, Jessica Weaver, Kristen A. Feemster, Bianca Chun, Thomas W. Weiss, Jordana K Schmier |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2024 |
Předmět: | |
Zdroj: | Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024) |
Druh dokumentu: | article |
ISSN: | 21645515 2164-554X 2164-5515 |
DOI: | 10.1080/21645515.2024.2325745 |
Popis: | ABSTRACTAs higher-valent pneumococcal conjugate vaccines (PCVs) become available for pediatric populations in the US, it is important to understand healthcare provider (HCP) preferences for and acceptability of PCVs. US HCPs (pediatricians, family medicine physicians and advanced practitioners) completed an online, cross-sectional survey between March and April 2023. HCPs were eligible if they recommended or prescribed vaccines to children age |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |